Search for: "EISAI, INC."
Results 21 - 40
of 93
Sorted by Relevance
|
Sort by Date
28 Jul 2008, 7:01 pm
EISAI v. [read post]
26 Sep 2017, 2:00 pm
Eisai Inc. announced this week it had signed a 40,000-square-foot ... [read post]
18 Nov 2007, 5:57 pm
Eisai Co., Ltd. et al. v. [read post]
25 Oct 2021, 7:36 am
The defendants in the Belviq lawsuits, Arena Pharmaceuticals and Eisai, Inc., have recently filed motions to dismiss in many of these cases. [read post]
25 Oct 2021, 7:36 am
The defendants in the Belviq lawsuits, Arena Pharmaceuticals and Eisai, Inc., have recently filed motions to dismiss in many of these cases. [read post]
18 May 2012, 8:47 pm
Donna Meuth, Senior Patent Counsel, Intellectual Property for Eisai Inc. will moderate a panel including Robert W. [read post]
25 Jul 2008, 2:11 am
Teleflex Inc., 127 S. [read post]
18 Jul 2016, 7:26 am
Eisai, Inc. v. [read post]
11 Oct 2013, 9:34 pm
Meuth, Associate General Counsel, Intellectual Property for Eisai Inc.; Kelly L. [read post]
5 May 2013, 9:44 pm
Eisai R&D Management Co., Ltd. v. [read post]
18 Dec 2007, 9:05 pm
Eisai's presence in the U.S. [read post]
2 Jun 2011, 6:02 am
Title: Eisai Co. v. [read post]
8 Jul 2014, 11:47 am
It was the disputed issue in Eisai, Inc. v. [read post]
22 Jul 2008, 7:51 pm
Teleflex Inc., 127 S. [read post]
5 May 2020, 1:37 pm
How To Know if Belviq Injured You In February 2020, pharmaceutical manufacturer Eisai, Inc. withdrew its weight-management drug Belviq (generic name lorcaserin) from the U.S. market at the request of the United States Food and Drug Administration (FDA) after a clinical trial identified an increased occurrence of cancer in people who took it. [read post]
15 May 2020, 11:48 am
As according to the responsible drug company, Eisai, Inc., on its Belviq.com website: BELVIQ was approved in June 2012 by the FDA as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related co-morbid condition, and was launched in the United States in June 2013. [read post]
4 Feb 2021, 8:31 am
In response to the FDA safety announcement for Belviq, Easai Inc. agreed to voluntarily withdraw the drug from the market. [read post]
14 Feb 2020, 5:23 am
Excess Cases Of Pancreatic Cancer, Colon Cancer, Rectal Cancer, And Lung Cancer Observed In Belviq Safety Clinical Trial (Posted by Tom Lamb at DrugInjuryWatch.com) On February 13, 2020 the FDA requested Eisai Inc. to voluntarily withdraw its diet drug Belviq because a Belviq safety clinical trial shows an increased occurrence of cancer cases. [read post]
13 Apr 2011, 5:13 pm
District Court for the District of Arizona (Phoenix Division) against Eisai, Inc. and Eisai Medical Research, Inc. [read post]
